Incorrect Survival Prediction Ups Aggressive End-of-Life Care

October 23, 2018 Kate Smith

Pam Harrison | October 23, 2018

An inability to accurately predict how long patients with metastatic lung cancer have left to live increases the likelihood of aggressive, poor-quality end-of-life care of dubious benefit, new research suggests.

← Advance Care Planning: ADs and POLST
Changes Over Time in the Oregon POLST Registry →